Substandard and falsified medical products are increasingly threatening public health, particularly in South Africa. These products, often sold through informal markets and unregulated online platforms, include unapproved weight-loss injections and unsafe painkillers. A growing number of individuals, like Anna, are turning to the black market for medications after experiencing stock shortages in licensed pharmacies. The South African Health Products Regulatory Authority (Sahpra) has identified a rise in health product quality complaints, with reports jumping from 101 in 2021/2022 to nearly 300 in 2022/2023. The World Health Organization (WHO) has also reported that 1 in 10 medicines in low- and middle-income countries are substandard or falsified, highlighting a global public health challenge that is also evident in South Africa, where the number of complaints regarding non-compliance continues to rise.
Why It Matters
The proliferation of substandard and falsified medical products poses serious health risks, especially in low- and middle-income countries like South Africa, where regulatory oversight is often limited. The WHO estimates that the issue affects all regions, with a significant increase in reports of compromised medications in South Africa, indicating a growing public health crisis. The lack of complete data on the prevalence of these products complicates efforts to combat their distribution. Historical trends show that unregulated markets frequently exploit gaps in health systems, leading to increased consumer vulnerability and potential harm from ineffective or harmful medications.
Want More Context? 🔎
